Skip to main content

Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 17 stocks, with a combined market cap of $2,672 billion, total revenue of $615.94 billion and a weighted average PE ratio of 22.99.

Market Cap
2,672.00B
Revenue
615.94B
Profits
116.22B
PE Ratio
22.99
Profit Margin
18.87%
Dividend Yield
2.24%

17 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company553.37B
0.36%
1,989,70232.07B
2JNJJohnson & Johnson377.32B
0.10%
2,796,70295.33B
3MRKMerck & Co., Inc.276.26B
0.23%
5,884,34959.31B
4ABBVAbbVie Inc.273.61B
0.14%
3,056,81255.14B
5AZNAstraZeneca PLC208.77B
0.07%
3,354,72045.00B
6NVSNovartis AG208.59B
1.00%
956,69852.32B
7PFEPfizer Inc.162.56B-30,035,47068.54B
8AMGNAmgen Inc.154.14B
-0.15%
1,766,79926.83B
9SNYSanofi124.71B
0.71%
639,03050.70B
10BMYBristol-Myers Squibb Company104.40B
0.18%
9,027,77744.94B
11GILDGilead Sciences, Inc.100.94B
-0.16%
3,586,92627.39B
12GSKGSK plc75.53B
-0.08%
1,488,19935.73B
13BIIBBiogen Inc.37.50B
-0.69%
802,8169.99B
14GRFSGrifols, S.A.10.27B
9.89%
2,654,9986.45B
15OGNOrganon & Co.3.69B
-0.41%
2,708,0906.15B
16SCLXScilex Holding Company322.13M
10.87%
1,131,26545.20M
17MIRAMIRA Pharmaceuticals, Inc.15.52M
-4.55%
91,256-